Now the same consistent performance you've experienced with PZI VET® (protamine zinc insulin) is available in a recombinant human protamine zinc insulin: new PROZINC.
PROZINC is the first long-acting protamine zinc insulin with FDA approval specifically for use in cats with diabetes mellitus.
This website offers important information on PROZINC and tools to help pet owners provide good care for their diabetic cats. Use the links on the left to find information for veterinary professionals, including published papers and opinions about PROZINC from leading experts in feline diabetes, news releases, product updates, and promotions currently available for
your hospital.
If you would like more information or have specific questions about PROZINC,
please contact Boehringer Ingelheim at 1-866-638-2226.
Important safety information
Animals presenting with severe ketoacidosis, anorexia, lethargy, and/or vomiting should be stabilized with short-acting insulin and appropriate supportive therapy until their condition is stabilized. As with all insulin products, careful patient monitoring for hypoglycemia and hyperglycemia are essential to attain and maintain adequate glycemic control and to prevent associated complications. Overdosage can result in profound hypoglycemia and death. Progestogens, certain endocrinopathies and glucocorticoids can have an antagonistic effect on insulin activity. Progestogen and glucocorticoid use should be avoided. Please refer to the package insert for complete product information.